BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Aeon Astron Corporation announces the brand ologen™ and related matters.

8 May 2008: Aeon Astron Corporation (AAC) today announces that the ologen™ is a brand owned by AAC group. This ologen™ is currently represented by ologen™ collagen matrix and ologen™ bandage lens. The collagen matrix is applied to glaucoma surgery and pterygium surgery and other selected ophthalmic applications. The usage has been approved by glaucoma specialists in many countries and approved the efficacy and enhancement of glaucoma surgery success. This collagen matrix is supplied in different sizes and shape, such as cylinder, rectangular, donut and round for different purposes. The ologen™ bandage lens is used as an eye protection or dressing fixation.

The ologen™ was formerly called as oculusgen. Due to impossible worldwide registration, ologen™ was then named and registered. The ologen™ has no relation to any company other than Aeon Astron Corporation group. The product production is strictly following 93/42/EEC Directive and Aeon Astron Europe BV is legally the CE certificate holder.

AAC will diligently protects its ologen™ brand. Anyone is trying to harm, misuse, misinterpretation or connection without proper manner will cause possible legal offense, claim and litigation. Anyone declares the rename of ologen™ will run into legal problem. AAC will take action immediately when any evidence is found.

AAC is dedicated into the ophthalmology and life science product and technology development. The existing business covers ologen™ collagen matrix, ologen™ bandage lens and aongen™ collagen matrix and aongen™ dental. The aongen™ brand applies to dental, plastic and general surgery.

For future ophthalmic product development, AAC is working with bio cornea, HA matrix and drug bonding and embedding for controlled and target release. Other research and development is concerning to aesthetic plastic, orthopedic and drug bonding platform. AAC is working to be the innovative and responsible company to provide bio ophthalmic products internationally.

Contact Info:
Aeon Astron Corporation
Tel: +886 2 27717098
Tel: +886 2 27218516
Aeon Astron Europe BV
Tel: +31 71 3322280
Fax: +31 71 3322281
Email:
praae@aeonastron.net 
web:
www.ologen.com, www.aeonastron.com 
 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.